EXPERTISE PARTNER
WuXi TIDES
WuXi TIDES, a unique Contract Research and Development Manufacturing Organization (CRDMO) platform, is an integral part of WuXi AppTec. WuXi TIDES offers our worldwide partners efficient, flexible, and high-quality solutions for the drug development of oligonucleotides, peptides and related synthetic conjugates (“TIDES” drugs). We greatly simplify the TIDES drug development by providing all discovery, CMC development and the entire manufacturing supply chain under one roof.
EVENT PARTNER
Hongene
Established in 1998, Hongene Biotech has been specialized in the production of nucleic acid raw materials for more than 25 years, covering nucleosides and modified nucleosides, nucleotides, phosphoramidite, GalNAc delivery molecules and enzymes. The annual capacity of phosphoramidite is 58 tons and nucleoside triphosphates is 54,000 litres (equivalent of 1.05 billion doses of mRNA vaccines). To date, Hongene has over 1,600 employees globally with over 400 R&D staff. Hongene brand is highly recognized by major pharmaceutical companies and biotech companies developing mRNA and oligonucleotide drugs. Hongene's products have entered almost all nucleic acid drug pipelines worldwide. During the Covid 19 pandemic, Hongene was the largest supplier of raw materials used in billions of mRNA COVID-19 vaccines. Currently, the company has established end-to-end mRNA CDMO capability, provide one-stop shopping from raw materials to final product, supporting clients from preclinical research to commercialization.
EXHIBITION PARTNERS
ChemGenes
ChemGenes, an ISO 9001 certified company established in 1981, is the industry leader in manufacturing oligonucleotide synthesis reagents and has consistently provided the highest quality phosphoramidites and solid supports in the market. Our facility, just outside of Boston/Cambridge Massachusetts USA, is setup for bulk manufacturing of therapeutic grade phosphoramidite and solid support DNA/RNA synthesis products for GMP grade oligonucleotide manufacturing. ChemGenes carries the widest variety of modified phosphoramidites and supports currently used in oligonucleotide synthesis including Microarray Technology, Oligonucleotide Therapeutics, Oligonucleotide Based Probes and other areas of Nucleic Acid research. In addition, ChemGenes is expanding its custom oligonucleotide synthesis department specializing in the manufacture of ASOs, siRNA, gRNA, gapmers, aptamers, DNA based probes, and superior quality beads for Single Cell mRNA sequencing applications using Drop-Seq, Slide-seq, and Seq-Well methods. ChemGenes remains devoted to providing you with invaluable customer service and comprehensive technical support.
Cytiva
From pioneering research to innovative vaccines and therapies, our customers are transforming medicine and saving lives. Now, Cytiva and Pall Life Sciences are joining forces to best support this vital work. As one company, we offer the tools, depth, breadth, and scale the life science community needs to work better, faster, and smarter. Let’s advance the next generation of therapeutics from discovery to delivery, together.
LGC Axolabs
Axolabs is the leading service provider for the discovery, development and manufacture of therapeutics based on DNA or RNA. Leveraging 20+ years of expertise in oligonucleotide research and drug development for the benefit of our customers, we deliver integrated solutions for research and development encompassing chemistry, biology and analytics of nucleic acid therapeutics to the manufacture of the active ingredients.